作者
Hyun Young Shin,Yeon Suk Kim,Eun Ji Ha,Ja Pyeong Koo,Won Bi Jeong,Mi Yeun Joung,Kwang‐Soon Shin,Kwang‐Won Yu
摘要
Centella asiatica (CA) has been reported to exert pharmacological effects on inflammatory diseases. In particular, CA possesses anti-inflammatory effects on macrophages; however, the precise intracellular mechanisms remain unclear. This study aimed to investigate the anti-inflammatory activity and intracellular signaling mechanism of a CA-active extract in a LPS-induced macrophage model of inflammation. In addition, FTIR spectra and RP-HPLC were used to analyze the centelloid compounds with known anti-inflammatory activity. We found that 70% EtOH extract (CA-70E) from CA alleviated oxidative damage and inflammation by reducing intracellular ROS formation and the secretion of pro-inflammatory factors (NO, TNF-α, MCP-1, and IL-6). CA-70E inhibited the mRNA expression of inflammatory factors (iNOS, TNF-α, MCP-1, IL-6, IL-12, and COX-2) as well as phagocytic activity. Additionally, it suppressed the phosphorylation cascade of pro-inflammatory proteins and nuclei translocation of activated p65 protein in MAPK and NF-κB signaling system. The antagonistic study using anti-PRRs revealed that CA-70E decreased the secretion of TNF-α, MCP-1, and IL-6 by binding to TLR4, CR3, CD14, and dectin-1 receptors. Meanwhile, FTIR spectra and RP-HPLC analyses showed that among the major centelloids, asiaticoside was the most abundant in CA-70E. We suggest that 70% EtOH extract of C. asiatica, with asiaticoside as a major compound, suppresses the phosphorylation in MAPK and NF-κB signaling pathways primarily via its action on TLR4, CR3, CD14, and dectin-1 receptors, thus decreasing the secretion of TNF-α, IL-6, and MCP-1.